Bank of America
PDSB icon

Bank of America’s PDS Biotechnology PDSB Stock Holding History

Bank of America’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,028
Closed -$791 – 6573
2025
Q4 		$791 Sell
1,028
-9
-0.9% -$8 ﹤0.01% 6495
2025
Q3 		$1.05K Buy
1,037
+389
+60% +$457 ﹤0.01% 7488
2025
Q2 		$861 Sell
648
-26,306
-98% -$35.7K ﹤0.01% 7564
2025
Q1 		$32.1K Buy
26,954
+15
+0.1% +$21 ﹤0.01% 6850
2024
Q4 		$43.9K Sell
26,939
-13
-0% -$34 ﹤0.01% 6660
2024
Q3 		$103K Sell
26,952
-18,083
-40% -$60.3K ﹤0.01% 6310
2024
Q2 		$132K Sell
45,035
-37,388
-45% -$120K ﹤0.01% 6110
2024
Q1 		$326K Sell
82,423
-2,529
-3% -$13K ﹤0.01% 5606
2023
Q4 		$422K Buy
84,952
+54,889
+183% +$273K ﹤0.01% 5611
2023
Q3 		$152K Sell
30,063
-3,361
-10% -$18.4K ﹤0.01% 6049
2023
Q2 		$168K Sell
33,424
-11,380
-25% -$74.5K ﹤0.01% 5952
2023
Q1 		$276K Buy
44,804
+17,326
+63% +$142K ﹤0.01% 5754
2022
Q4 		$363K Sell
27,478
-2,222
-7% -$15.7K ﹤0.01% 5594
2022
Q3 		$88K Sell
29,700
-31,831
-52% -$135K ﹤0.01% 6401
2022
Q2 		$225K Buy
61,531
+2,691
+5% +$12.8K ﹤0.01% 6006
2022
Q1 		$364K Buy
58,840
+54,668
+1,310% +$340K ﹤0.01% 6047
2021
Q4 		$34K Buy
4,172
+4,114
+7,093% +$44.3K ﹤0.01% 7358
2021
Q3 		$1K Sell
58
-147
-72% -$1.83K ﹤0.01% 7994
2021
Q2 		$2K Buy
205
+99
+93% +$773 ﹤0.01% 7551
2021
Q1 		$0 Buy
106
+91
+607% +$366 ﹤0.01% 7688
2020
Q4 		$0 Hold
15
– – ﹤0.01% 7294
2020
Q3 		$0 Hold
15
– – ﹤0.01% 7105
2020
Q2 		$0 Hold
15
– – ﹤0.01% 7048
2020
Q1 		$0 Sell
15
-250
-94% -$433 ﹤0.01% 7142
2019
Q4 		$1K Sell
265
-316
-54% -$900 ﹤0.01% 6970
2019
Q3 		$2K Buy
581
+462
+388% +$2.69K ﹤0.01% 7007
2019
Q2 		$1K Sell
119
-32
-21% -$209 ﹤0.01% 7048
2019
Q1 		$1K Buy
151
+136
+907% +$1.14K ﹤0.01% 6986
2018
Q4 		$0 Hold
15
– – ﹤0.01% 7307
2018
Q3 		$0 Sell
15
-695
-98% -$12.5K ﹤0.01% 7418
2018
Q2 		$15K Sell
710
-4,381
-86% -$91.4K ﹤0.01% 6579
2018
Q1 		$120K Buy
5,091
+4,808
+1,699% +$1.29M ﹤0.01% 5652
2017
Q4 		$53K Buy
283
+195
+222% +$39.2K ﹤0.01% 6044
2017
Q3 		$19K Buy
88
+70
+389% +$14.5K ﹤0.01% 6300
2017
Q2 		$3K Sell
18
-151
-89% -$29.8K ﹤0.01% 6678
2017
Q1 		$31K Buy
169
+41
+32% +$8.12K ﹤0.01% 6126
2016
Q4 		$32K Buy
128
+94
+276% +$21.4K ﹤0.01% 6124
2016
Q3 		$7K Buy
34
+19
+127% +$3.76K ﹤0.01% 6498
2016
Q2 		$3K Buy
+15
New +$2.65K ﹤0.01% 6813
2016
Q1 		– Sell
-10
Closed -$3K – 7238
2015
Q4 		$3K Buy
+10
New +$3.22K ﹤0.01% 7021

Other funds holding PDSB

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America's PDSB Position: Q1 2026 in Review

Bank of America sold out of PDS Biotechnology (PDSB) in Q1 2026, closing a stake of 1,028 shares — an estimated $791 sold.

Bank of America first reported a position in PDSB in Q4 2015 and held it in 40 quarters. The position peaked at $422K in Q4 2023. 41 funds tracked by Wall St. Rank hold PDSB as of Q1 2026.

  • Bank of America reported no remaining PDS Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 1,028 PDS Biotechnology shares in Q1 2026, an estimated $791.
  • Bank of America first reported a position in PDS Biotechnology in Q4 2015 and held it in 40 quarters.
  • Bank of America's PDS Biotechnology position peaked at $422K in Q4 2023.
  • 41 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.